The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1245/s10434-022-12990-3.pdf
Reference43 articles.
1. Witmer H, Turaga K. Current indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal malignancies. Adv Oncol. 2021;1:49–61. https://doi.org/10.1016/j.yao.2021.02.005.
2. Valle M, Van der Speeten K, Garofalo A. Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: a multi-institutional retrospective analysis in 52 patients. J Surg Oncol. 2009;100:331–4. https://doi.org/10.1002/jso.21321.
3. White MG, Badgwell BD. Laparoscopic heated intraperitoneal chemotherapy in the treatment of carcinomatosis of gastric adenocarcinoma origin. J Clin Med. 2021;10(20):4757. https://doi.org/10.3390/jcm10204757.
4. Zhang C, Patel A, Hegeholz D, et al. Cytoreductive surgery with HIPEC is a safe and effective palliative option in chemo refractory symptomatic peritoneal metastasis. Ann Surg Oncol. 2022;29:3337–46. https://doi.org/10.1245/s10434-022-11323-8.
5. Bhatt A, Glehen O. Extent of peritoneal resection for peritoneal metastases: looking beyond a complete cytoreduction. Ann Surg Oncol. 2020;27(5):1458–70. https://doi.org/10.1245/s10434-020-08208-z.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Pseudomyxoma Peritonei;Annals of Surgical Oncology;2024-07-15
2. Predicting Survival in Mucinous Adenocarcinoma of the Appendix: Demographics, Disease Presentation, and Treatment Methodology;Annals of Surgical Oncology;2024-06-14
3. Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients;World Journal of Surgical Oncology;2024-05-31
4. Long-Term Survival Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis of Hepatocellular Carcinoma patients;2024-03-29
5. La chimiothérapie intra-péritonéale dans le traitement de la carcinose péritonéale d’origine colorectale. CHIP, PIPAC, état des lieux et perspectives;Bulletin du Cancer;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3